wow888 jili
Biden says he was ‘stupid’ not to put his name on pandemic relief checks like Trump didFRISCO, Texas (AP) — Dallas Cowboys linebacker DeMarvion Overshown could miss the 2025 season recovering from the right knee injury sustained in a loss to Cincinnati, coach Mike McCarthy said Tuesday. McCarthy said Overshown has a “long road of rehab in front of him.” The second-year player tore multiple ligaments when a Bengals lineman crashed into his leg in the Cowboys' 27-20 loss Monday night. Overshown missed all of his rookie year in 2023 after tearing the ACL in his left knee in a preseason game. The latest injury came in his first game since a spectacular 23-yard interception return for a touchdown in a 27-20 victory over the New York Giants on Thanksgiving. “DeMarvion is getting ready to have a big surgery in front of him,” McCarthy said of the procedure planned this week. “His physical and football talent speaks for itself. He’s such a bright light. He’s got a great, infectious personality — a tough young man. He is definitely going to be missed.” The former Texas standout, drafted in the third round last year, was second on the team to star pass rusher Micah Parsons with five sacks when he went down. The December timing of Overshown's injury means rehab is likely to extend past training camp and into the regular season next year, after he turns 25. Parsons was emotional when asked about Overshown after the Cincinnati game. “I cried,” he said. “It’s like my little bro, bro. He doesn’t deserve that either. Just to understand what he’s going to go through and to be there for him physically, mentally. It’s just so challenging because of the year he was having. I really just don’t think that’s fair either.” The loss of Overshown comes with defensive end DeMarcus Lawrence close to return from a foot injury that has sidelined him since Week 4. But the Cowboys (5-8) are all but out of the playoffs as they prepare to visit Carolina (3-10) on Sunday. AP NFL: https://apnews.com/hub/nfl
None
Saints vs. Raiders Predictions & Picks: Odds, Moneyline, Spread – Week 17Soccer: Fischer Earns Academic All-Summit Honors For USD
Mainstream Media Ignores Sectarian Killings In 'Liberated' Syria While Jolani Plays Nice For Cameras
Why celebrity investor Kevin O'Leary is proposing a massive AI data centre in northern AlbertaJRS stock hits 52-week high at $9.45 amid robust annual growth
SAN DIEGO , Dec. 10, 2024 /PRNewswire/ -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Xerox Holdings Corporation (NASDAQ: XRX ) securities between January 25, 2024 and October 28, 2024 . Xerox and its subsidiaries offer workplace technology that integrates hardware, services, and software for enterprises in the Americas, and internationally. For more information, submit a form , email attorney Aaron Dumas, Jr. , or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Xerox Holdings Corporation (XRX) Misled Investors Regarding its Business Prospects According to the complaint, during the class period, defendants failed to disclose to investors that: (1) after a large workforce reduction, the Company's salesforce was reorganized with new territory assignments and account coverage; (2) as a result, the Company's salesforce productivity was disrupted; (3) as a result, the Company had a lower rate of sell-through of older products; (4) the difficulties in flushing out older product would delay the launch of key products; and (5) therefore, Xerox was likely to experience lower sales and revenue. Plaintiff alleges that on October 29, 2024 , Xerox revealed "lower-than-expected improvements in sales force productivity" and "delays in the global launch of two new products" had led to "sales underperformance." The Company disclosed that for third quarter 2024, quarterly revenue was down 7.5% year-over-year to $1.53 billion , net loss fell to - $1.2 billion (down $1.3 billion year-over-year), and equipment sales declined 12.2% year over year to $339 million . In a corresponding earnings call, the Company's COO revealed the product delay was in fact a "forecasting issue" where the Company "had higher expectations that we were going to flush through the older product" which it needed to "sell through" in order to "make those transitions." On this news, the Company's share price fell $1.79 , or 17.41%, to close at $8.49 per share on October 29, 2024 . What Now : You may be eligible to participate in the class action against Xerox Holdings Corporation. Shareholders who want to serve as lead plaintiff for the class must submit their application to the court by January 21, 2025 . A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here . All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Robbins LLP : Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders. To be notified if a class action against Xerox Holdings Corporation settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today. Attorney Advertising. Past results do not guarantee a similar outcome. SOURCE Robbins LLP
Farage: Badenoch must apologise for ‘crazy conspiracy theory’ on Reform numbers